Gulf Pharmaceutical Industries
Last Updated:
- 1.050 AED
- -0.010
- -0.94%
شركة الخليج للصناعات الدوائية
جلفار
Symbol :
JULPHAR
ISIN :
AEG000201018
52-Week Range :
0.998
-
1.610
Turnover Ratio :
0.66
Market :
Abu Dhabi Securities Exchange
Sector :
FTSE ADX Health Care Index
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Gulf Pharmaceutical Industries Announcements
Top News
- A 15-February Julphar generates higher net profits at AED 175m in 2025
- B 14-August Julphar turns into profitability in H1-25 backed by operations in Egypt
- C 17-November Julphar’s drives portfolio progress in MENA with 14% higher sales in 9M-24
- D 18-August Julphar sees lower net losses in H1-24; revenues up 3%
- E 15-May Julphar turns profitable in Q1-24; accumulated losses announced
- F 17-March Julphar’s 2023 accumulated losses hit 30% of capital; revenues up
- G 13-November Julphar turns to losses in 9M-23; accumulated losses reach 29% of capital
- H 14-August Julphar unveils H1-23 financials; accumulated losses hit AED 295.5m
- I 17-May Julphar shifts to losses in Q1-23; accumulated losses unveiled
- J 09-February Julphar’s CEO resigns; Ziyadeh assumes position
- K 10-November Julphar’s profits to equityholders shrink to AED 10.5m in 9M-22
- L 16-May Julphar turns to profitability in Q1-22
